Loading clinical trials...
Loading clinical trials...
Immunophenotyping in Metastatic Renal Cell Carcinoma Patients Receiving Ablative Therapy
Conditions
Interventions
Biospecimen Collection
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
January 24, 2022
Primary Completion Date
May 15, 2024
Completion Date
May 15, 2024
Last Updated
August 9, 2024
NCT04693377
NCT06500455
NCT06863311
NCT07123090
NCT06391099
NCT06349642
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions